首页> 外文OA文献 >First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity

【2h】

First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity

机译：转移性乳腺癌的一线化学免疫疗法：紫杉醇和IMP321（LAG-3Ig）的组合可增强免疫反应和抗肿瘤活性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Chrystelle Brignone; Maya Gutierrez; Fawzia Mefti; Etienne Brain; Rosana Jarcau; Frédérique Cvitkovic; Nabil Bousetta; Jacques Medioni; Joseph Gligorov; Caroline Grygar; Manon Marcu; Frédéric Triebel;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 来自一项艾日布林联合吉西他滨对比紫杉醇联合吉西他滨作为HER2阴性转移性乳腺癌的一线化疗的II期、多中心、随机试验的包含神经病变相关量表的生活质量结果:韩国癌症研究组试验(KCSG BR13-11) [J] . Ji-Yeon Kim, Young-Hyuck Im, Tae-Yong Kim, 癌症（英文版） . 2019,第008期
2. First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity [J] . Chrystelle Brignone, Maya Gutierrez, Fawzia Mefti, Journal of Translational Medicine . 2010,第1期

机译：转移性乳腺癌的一线化学免疫疗法：紫杉醇和IMP321（LAG-3Ig）的组合可增强免疫应答和抗肿瘤活性
3. AIPAC: a Phase IIb study of eftilagimod alpha (IMP321 or LAG-3Ig) added to weekly paclitaxel in patients with metastatic breast cancer [J] . Dirix Luc, Triebel Frederic Future oncology . 2019,第17期

机译：AIPAC：在转移乳腺癌患者中添加到每周紫杉醇的EFTilagimodα（IMP321或LAG-3ig）的IIIb研究
4. Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients-Report of a Phase I/IIa Clinical Trial [J] . Legat Amandine, Maby-El Hajjami Helene, Baumgaertner Petra, Clinical cancer research: an official journal of the American Association for Cancer Research . 2016,第6期

机译：在转移性黑素瘤患者中接种LAG-3Ig（IMP321）和多肽疫苗可诱导特异性CD4和CD8 T细胞应答-I / IIa期临床试验报告
5. Passive adoptive transfer of antitumor immunity induced by laser-dye-immunoadjuvant treatment in a rat metastatic breast cancer model [C] . Wei R. Chen, Hong Liu, Anil K. Singhal, Conference on Laser-Tissue Interaction XI: Photochemical, Photothermal, and Photomechanical 22-27 January 2000 San Jose, USA . 2000

机译：激光染料-免疫佐剂治疗引起的大鼠转移性乳腺癌模型的抗肿瘤免疫被动过继转移
6. Enhancement of Gemcitabine and Paclitaxel Uptake and Retention in Metastatic Cancer Cells: A Novel Targeted Combination Delivery Approach to Eliminate Breast Cancer in Blood and Lymph [D] . Yu, Jesse. 2020

机译：吉西他滨和紫杉醇吸收的增强和转移性癌细胞的保留：一种小型靶向组合递送方法，消除血液和淋巴中的乳腺癌
7. First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity [O] . Chrystelle Brignone, Maya Gutierrez, Fawzia Mefti, 2010

机译：转移性乳腺癌的一线化学免疫疗法：紫杉醇和IMP321（LAG-3Ig）的组合可增强免疫反应和抗肿瘤活性
8. First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity [O] . Brignone, Chrystelle, Gutierrez, Maya, Mefti, Fawzia, 2010

机译：转移性乳腺癌的一线化学免疫疗法：紫杉醇和IMP321（LAG-3Ig）的组合可增强免疫反应和抗肿瘤活性

First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity

著录项

引文网络

相似文献

相关主题

期刊订阅